TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Idexx Laboratories Norge AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
13,896
|
12,355
|
105,153 |
Financial expenses |
8
|
0
|
1 |
Earnings before taxes |
2,755
|
2,335
|
1,738 |
Total assets |
30,857
|
26,314
|
30,271 |
Current assets |
30,502
|
25,837
|
29,569 |
Current liabilities |
15,552
|
12,149
|
18,239 |
Equity capital |
14,632
|
13,385
|
11,226 |
- share capital |
118
|
127
|
123 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
47.4%
|
50.9%
|
37.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
19.8%
|
18.9%
|
1.7% |
Return on assets (ROA) |
9.0%
|
8.9%
|
5.7% |
Current ratio |
196.1%
|
212.7%
|
162.1% |
Return on equity (ROE) |
18.8%
|
17.4%
|
15.5% |
Change turnover |
2,359
|
-96,056
|
15,678 |
Change turnover % |
20%
|
-89%
|
18% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.